Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,546.80
(
0.11%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
96.80
(
0.31%
)
Bitcoin
71,110.20
(
0.84%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 188402

Monday, 04/20/2015 9:54:45 AM

Monday, April 20, 2015 9:54:45 AM

Post# of 257275
AGTC inks AAV deal with (private) 4D Molecular Therapies:

http://finance.yahoo.com/news/agtc-4d-molecular-therapeutics-sign-110000790.html

Applied Genetic Technologies Corporation and 4D Molecular Therapeutics (4DMT)…today announced a collaboration and license agreement to discover and develop optimized AAV vectors to treat specific ophthalmic disease indications with high unmet medical need. As part of the agreement, 4DMT will deploy its proprietary AAV vector discovery platform, Directed Vector Evolution, to identify and optimize novel vectors. Financial details were not disclosed.

This deal is somewhat curious insofar as AGTC has claimed to have industry-leading expertise in AAV vectors; if that were true, why would they need 4DMT?

AGTC is down 2% today.

Comments welcome.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today